Conjugated Linoleic Acid Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors
Condition: Advanced Solid TumorsInterventions: Dietary Supplement: Conjugated Linoleic Acid; Drug: Conjugated Linoleic AcidSponsors: Dartmouth-Hitchcock Medical Center; National Cancer Institute (NCI)Terminated - verified March 2012 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2009 Category: Research Source Type: clinical trials